Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05089929 · ClinicalTrials.gov registry record
Endoscopic Esophageal Topography (Endoflip 2.0) Versus High-resolution Manometry (HRM)
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 55
- Enrollment target
NCT05089929: Completed study, sponsored by Ohio State University.
NCT05089929 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 55 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05089929 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 55 participants
- Enrollment target
Study Summary
The purpose of the study is to investigate the use of FLIP topography in patients undergoing evaluation for gastroesophageal reflux disease (GERD). This device allows the clinician to measure muscle activity in the esophagus during a routine upper endoscopy. The FLIP topography will be used to help detect movement disorders in the esophagus, and to examine differences in patient satisfaction between FLIP topography and the standard of care procedure, high resolution manometry (HRM).
Primary Outcome
Evaluate the concordance between the presence of RACs on FLIP topography versus the absence of major motility disorder on HRM as defined by the Chicago classification system v3.
Interventions
- DEVICE Endoflip 2.0
- PROCEDURE High Resolution Manometry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2020-03-19 |
| Est. Completion | 2023-06-30 |
What the finished NCT05089929 record still lists
NCT05089929 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 55 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Endoflip 2.0 is the first listed.
NCT05089929 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05089929 about?
NCT05089929 is a clinical study titled "Endoscopic Esophageal Topography (Endoflip 2.0) Versus High-resolution Manometry (HRM)". The purpose of the study is to investigate the use of FLIP topography in patients undergoing evaluation for gastroesophageal reflux disease (GERD). This device allows the clinician to measure muscle activity in the esophagus during a routine upper endoscopy. The FLIP topography will be used to help ...
What is the current status of trial NCT05089929?
This trial is currently completed. The enrollment target is 55 participants. The study started on 2020-03-19. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT05089929?
The interventions under investigation include: Endoflip 2.0 (DEVICE), High Resolution Manometry (PROCEDURE).
Who is sponsoring clinical trial NCT05089929?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI